Stockreport

Nektar Therapeutics (NKTR) Reports Fiscal Year-End and Q4 2023 Results [Yahoo! Finance]

Nektar Therapeutics  (NKTR) 
Last nektar therapeutics earnings: 2/27 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.nektar.com/investor-relations
PDF Net Loss : Decreased to $42.1 million in Q4 2023, down from $59.7 million in Q4 2022. R&D Expenses : Decreased to $29.9 million in Q4 2023 from $34.7 million in Q4 20 [Read more]